Clinical consequences of sensitisation to minor histocompatibility antigens before allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 22, Issue 9, 1998, Pages 895-898

  Rufer, N ^a   Starobinski, M ^a   Chapuis, B ^a   Gratwohl, A ^b   Jeannet, M ^a   Helg, C ^a   Roosnek, E ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cytotoxic T lymphocytes; Marrow transplantation; Minor histocompatibility antigens; Rejection

Indexed keywords

CYCLOPHOSPHAMIDE; HLA ANTIGEN; HY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; LEUKEMIA; MALE; PRIORITY JOURNAL; SIBLING;

EID: 0031739324     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701466     Document Type: Article

References (24)

1. Kernan NA, Bartsch G, Ash R et al. Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. New Engl J Med 1993; 328: 593-602.
2. Anasetti C, Howe C, Petersdorf EW et al. Marrow transplants from HLA-matched unrelated donors: an NMDP update and the Seattle experience. Bone Marrow Transplant 1994; 13: 693-695.
3. Gratwohl A, Hermans J. Bone marrow transplantation activity in Europe 1992: report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1994; 13: 5-10.
4. Ferrara JL, Deeg HJ. Graft-versus-host disease. New Engl J Med 1991; 324: 667-674.
5. Beatty PG, Anasetti C, Hansen JA et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993; 81: 249-253.
6. Storb R. Bone marrow transplantation. Transplant Proc 1995; 27: 2649-2652.
7. Patterson J, Prentice HG, Brenner MK et al. Graft rejection following HLA-matched T lymphocyte-depleted bone marrow transplantation. Br J Haematol 1986; 63: 221-230.
8. Rötzschke O, Falk K, Wallny HJ, et al. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science 1990; 249: 283-287.
9. Wallny HJ, Rammensee HG. Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature 1990; 343: 275-278.
10. Bevan MJ. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med 1975; 142: 1349-1364.
11. Goulmy E, Voogt P, van Els C et al. The role of minor histocompatibility antigens in GVHD and rejection: a mini-review. Bone Marrow Transplant 1991; 7 (Suppl. 1): 49-51.
12. Voogt PJ, Fibbe WE, Marijt WAF el al. Rejection of bone marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 1990; 335: 131-134.
13. Kaminski ER, Hows JM, Goldman JM, Batchelor JR. Pretransfused patients with severe aplastic anemia exhibit high numbers of cytotoxic T lymphocyte precursors probably directed at non-HLA antigens. Br J Haematol 1990; 76: 401-405.
14. Tekolf WA, Shaw S. In vitro generation of cytotoxic cells specific for human minor histocompatibility antigens by lymphocytes from a normal donor potentially primed during pregnancy. J Exp Med 1983; 157: 2172-2177.
15. Speiser D, Tiercy J-M, Rufer N et al. Relation between the resolution of HLA-typing and the chance of rinding an unrelated bone marrow donor. Bone Mumnv Transplant 1994; 13: 805-809.
16. Tiercy J-M, Grundshober C, Jeannet M, Mach B. A comprehensive HLA-DRB, -DQB, and -DPB oligotyping procedure by hybridization with sequence-specific oligonucTeotide probes. In Hui KMB (cd). Handbook of HLA Typing Techniques. CRC Press: Boca Raton, 1993, pp 117-147.
17. Tiercy J-M, Djavad N, Rufer N et al. Oligotyping of HLA A2, A3, and B44 subtypes: detection of subtype-incompatibilities between patients and their serologically matched unrelated bone marrow donors. Hum Inummol 1994; 41: 207-215.
18. Rufer N, Breur-Vriesendorp B, Tiercy J-M et al. HLA-B35-subtype mismatches in ABDR serologically matched unrelated donor-recipient pairs. Hum Imnnmol 1994; 41: 96-101
19. Kennedy LJ, Poulton KV, Dyer PA et al. Definition of HLA-C alleles using sequence-specific oligonucleotide probes (PCR-SSOP). Tiss Antigen 1995; 46; 187-195.
20. Rufer N, Breur-Vriesenciorp BS, Tiercy J-M et al. High-resolution histocompatibility testing of a group of 16 B44-positive. ABDR serologically matched unrelated donor-recipient pairs: analysis of serologically undisclosed incompatibilities by cellular techniques, isoelectrofocusing and HLA oligotyping. Hum Imnumol 1993; 38: 235-239.
21. Roosnek E, Lanzavecchia A, Triggering T cells by otherwise inert hybrid anti-CD3/antitumor antibodies requires encounter with the specific target cell. J Exp Med 1989; 170:
22. Schreuder GMT, Pool J, Blokland E et al. A genetic analysis of human histocompatibility antigens demonstrates Mendelian segregation independent of HLA. Immunogenetics 1993; 38: 98-105.
23. van Els CA, D Amaro J, Pool J et al. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics 1992; 35: 161-165.
24. Goulmy E, Schipper R, Pool J et al. Influence of minor histocompatibility antigen mismatches on the development of graft-versus-host disease after bone marrow transplantation from HLA identical donors. New Engl J Med 1996; 334: 281-285.